CIRRX | STMOX | CIRRX / STMOX | |
Total Expense Ratio | 1.25 | 1.86 | 67% |
Annual Report Gross Expense Ratio | 1.25 | 1.86 | 67% |
Fund Existence | 11 years | 10 years | - |
Gain YTD | 5.434 | 1.649 | 330% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 67.4M | 12,320% |
Annual Yield % from dividends | 2.37 | 1.42 | 166% |
Returns for 1 year | -1.53 | -7.59 | 20% |
Returns for 3 years | 33.77 | 2.29 | 1,475% |
Returns for 5 years | 29.65 | -1.95 | -1,520% |
Returns for 10 years | 56.65 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RICCX | 67.19 | 0.24 | +0.36% |
American Funds Invmt Co of Amer R3 | |||
JEVNX | 11.06 | N/A | N/A |
JHancock Disciplined Value Em Mkts EqNAV | |||
KLCCX | 12.27 | N/A | N/A |
Federated Hermes Kaufmann Large Cap C | |||
JFNAX | 72.17 | N/A | N/A |
Janus Henderson Global Life Sciences A | |||
FEQDX | 14.68 | N/A | N/A |
Fidelity Advisor Hedged Equity C |